Largest biotech by total liabilities

Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.

Amgen leads the 24 biotech ranked by total liabilities, at CHF 69.1B, ahead of Gilead Sciences (CHF 30.7B) and Biogen (CHF 9.4B). Figures as of 18 Nov 2026, 14:10 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
24
First
AmgenCHF 69.1B
Median
CHF 592.9M
Combined market value
CHF 716B
Countries
5

Market values as of .

Largest biotech by total liabilities
#CompanyTotal liabilities ↓Market capPriceToday1 yearPrice, 30 daysCountry
1AmgenAMGN · Health CareCHF 69.1BCHF 208.9BCHF 386.12 0.95% down 34% up United States
2Gilead SciencesGILD · Health CareCHF 30.7BCHF 178.1BCHF 143.56 1.60% up 33% up United States
3BiogenBIIB · Health CareCHF 9.4BCHF 31.3BCHF 211.46 0.34% down 49% up United States
4ModernaMRNA · Health CareCHF 3.1BCHF 70.6BCHF 174.37 3.93% down 755% up United States
5BioNTechBNTX · Health CareCHF 2.6BCHF 17.7BCHF 71.55 0.47% down 16% down Germany
6QiagenQGEN · Health CareCHF 2.1BCHF 8.7BCHF 41.95 0.12% down 12% up Netherlands
7Halozyme TherapeuticsHALO · Health CareCHF 2.1BCHF 9.2BCHF 80.92 0.55% down 37% up United States
8Neurocrine BiosciencesNBIX · Health CareCHF 1.2BCHF 14.2BCHF 139.90 0.37% up 20% up United States
9argenxARGX · Health CareCHF 1.1BCHF 50.2BCHF 798.93 0.36% down 4% up Belgium
10ImmunityBioIBRX · Health CareCHF 844.4MCHF 5.6BCHF 5.28 4.68% up 193% up United States
11RepligenRGEN · Health CareCHF 711.3MCHF 8.7BCHF 136.75 0.37% down 5% up United States
12Revolution MedicinesRVMD · Health CareCHF 609.8MCHF 29.7BCHF 137.18 2.50% down 131% up United States
13ExelixisEXEL · Health CareCHF 576MCHF 14.1BCHF 57.76 2.09% up 63% up United States
14Bio-TechneTECH · Health CareCHF 403.5MCHF 9.6BCHF 61.24 0.22% down 26% up United States
15CRISPR TherapeuticsCRSP · Health CareCHF 289.6MCHF 3.3BCHF 33.85 0.54% down 21% down Switzerland
16VaxcytePCVX · Health CareCHF 267.5MCHF 7.9BCHF 50.08 3.59% down 22% up United States
17Adaptive BiotechnologiesADPT · Health CareCHF 242.6MCHF 3.9BCHF 24.02 2.22% up 88% up United States
18Kodiak SciencesKOD · Health CareCHF 163.7MCHF 5.3BCHF 81.62 3.90% down 396% up United States
19Twist BioscienceTWST · Health CareCHF 142.4MCHF 6.4BCHF 94.44 6.63% up 340% up United States
20Kymera TherapeuticsKYMR · Health CareCHF 137.6MCHF 8.7BCHF 102.46 3.44% down 87% up United States
21Scholar Rock HoldingSRRK · Health CareCHF 133.9MCHF 4.6BCHF 38.01 1.21% up 14% up United States
22Krystal BiotechKRYS · Health CareCHF 96.3MCHF 7.5BCHF 251.73 0.22% up 46% up United States
23ImmunovantIMVT · Health CareCHF 88MCHF 5.8BCHF 28.00 0.21% down 43% up United States
24CG OncologyCGON · Health CareCHF 32.9MCHF 5.9BCHF 66.56 6.89% down 85% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total liabilities is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Where a company reports no total-liabilities line, it is worked out as assets less equity. Sums are converted from US dollars at today's exchange rate (1 USD = 0.8432 CHF).

Questions and answers

Which biotech rank first by total liabilities?

Amgen (CHF 69.1B), Gilead Sciences (CHF 30.7B) and Biogen (CHF 9.4B) are the top three of the 24 biotech ranked by total liabilities as of 18 Nov 2026, 14:10 UTC.

How many biotech are in this ranking?

24 are ranked by total liabilities.

What are these biotech worth together?

The 24 biotech ranked by total liabilities have a combined market value of CHF 716B as of 18 Nov 2026, 14:10 UTC.

What does ranking by total liabilities measure?

Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.

Cite this page

Funkfolio, “Largest biotech by total liabilities”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=total-liabilities

Underlying data: Yahoo Finance; SEC EDGAR.